Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the noble rat

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 131-139

  Ho, Shuk Mei ^a   Leav, Irwin ^a   Ghatak, Shibnath ^a   Merk, Frederick ^a   Jagannathan, Vehda S ^a   Mallery, Kevin ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; ESTRADIOL; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONAL CARCINOGENESIS; HORMONAL REGULATION; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; TRANSCRIPTION REGULATION;

EID: 0031870233     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65553-8     Document Type: Article

References (49)

1. Montpetit ML, Lawless KR, Tenniswood MP: Evidence for an androgen repressed mRNA in rat ventral prostate. Prostate 1995, 8:25-36
2. Collard MW, Griswold MD: Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 1987, 26:3297-3303
3. Griswold MD, Roberts K, Bishop P: Purification and characterization of a sulfated glycoprotein secreted by Sertoli cells. Biochemistry 1986, 25:7265-7270
4. Blaschuk O, Burdzy K, Fritz IB: Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 1983, 258:7714-7720
5. Palmer DJ, Christie DL: The primary structure of glycoprotein III from bovine adrenal medullary chromaffin granules: sequence similarity with human serum protein-40,40 and rat Sertoli cell glycoprotein. J Biol Chem 1990, 265:6617-6623
6. de Silva HV, Harmony JA, Stuart WD, Gil CM, Robbins J: Apolipopratein J: structure and tissue distribution. Biochemistry 1990, 29:5380-5389
7. Jenne DE, Tschopp J: Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 1989, 86:7123-7127
8. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE: Active cell death in hormone-dependent tissue. Cancer Metastasis Rev 1992, 11:197-220
9. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, Sawczuk IS: Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 1989, 9:3473-3481
10. May PC, Finch CE: Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration Trends Neurosci 1992, 15:391-396
11. Leger JG, Montpetit ML, Tenniswood MP: Characterization and cloning of androgen repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun 1987, 147:196-203
12. Kyprianou N, Isaacs JT: Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989, 3:1515-1522
13. Sensibar JA, Griswold MD, Sylvester SR, Buttyan R, Bardin CW, Cheng CY, Dudek S, Lee C: Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology 1991, 128:2091-2102
14. Russo P, Warner JA Huryk R, Perez G, Heston WD: TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin. Prostate 1994, 24:237-243
15. Norman DJ, Feng L, Cheng SS, Gubbay J, Chan E, Heintz N: The lurcher gene induces apoptotic death in cerebellar Purkinje cells. Development 1995, 121:1183-1193
16. Conner J, Buttyan R, Olsson CA, D'Agati V, O'Toole K, Sawczuk IS: SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 1991, 39:1098-1103
17. May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, Finch CE: Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 1990, 5:831-839
18. Gu Y, Jow GM, Moulton BC, Lee C, Sensibar JA, Park-Sarge OK, Chen TJ, Gibori G: Apoptosis in decidual tissue regression and reorganization. Endocrinology 1994, 135:1272-1279
19. Hurwitz A, Ruutiainen-Altman K, Marzella L, Bolero L, Dushnik M, Adashi EY: Follicular atresia as an apoptotic process: atresia-associated increase in the ovarian expression of the putative apoptotic marker sulfated glycoprotein-2. J Soc Gynecol Invest 1996, 3:199-208
20. Fleshner NE, Trachtenberg J: Sequential androgen blockade: a biological study in the inhibition of prostatic growth. J Urol 1992, 148: 1928-1931
21. Brandstrom A, Westin P, Bergh A, Cajander S, Damber JE: Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. Cancer Res 1994, 54:3594-5601
22. Akakura K, Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, Tenniswood M, Fox K: Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma. J Steroid Biochem Mol Biol 1996, 59:501-511
23. Rennie PS, Bruchovsky N, Akakura K, Goldenberg SL, Otal N, Akakura S, Wong P, Tenniswood M: Effect of tumor progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma. J Steroid Biochem Mol Biol 1994, 50:31-40
24. Marinelli M, Quaglino D, Bettuzzi S, Strocchi P, Davalli P, Corti A: Increased levels of clusterin mRNA in the ventral prostate of the aging rat are associated to increases in cuboidal (atrophic) cell population and not to changes in apoptotic activity. Biochem Cell Biol 1994, 72:512-521
25. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D: Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988, 80: 1045-1053
26. Leav I, Merk FB, Kwan PW, Ho SM: Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 1989, 15:23-40
27. McNeal JE, Bostwick DG: Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986, 17:64-71
28. Bostwick DG, Pacelli A, Lopqez-Beltran A: Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996, 29:117-134
29. Drago JR: The induction of NB rat prostatic carcinomas. Anticancer Res 1984, 4:255-256
30. Bosland MC, Ford H, Norton L: Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol 17β or diethylstilbestrol. Carcinogenesis, 1994, 16:1311-1317
31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
32. Chomczynski P: One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem 1992, 201:134-139
33. Clements JA, Matheson BA, Wines DR, Brady JM, MacDonald RJ, Funder JW: Androgen dependence of specific kallikrein gene family members expressed in rat prostate. J Biol Chem 1988, 263:16132-16137
34. Höfler H, Childers H, Montminy MR, Lechan RM, Goodman RH, Wolfe HJ: In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 1986, 18:597-604
35. 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization: expression of mRNA of the seminal vesicle protein II and androgen-receptor genes in the rat prostate. Histochemistry 1992, 98:217-218
36. Hendy GN, Kronenberg HM, Potts JT Jr, Rich A: Nucleotide sequence of cloned cDNAs encoding human preproparathyroid. Proc Natl Acad Sci USA 1981, 78:408-413
37. Grima J, Zwain I, Lockshin RA, Bardin CW, Cheng CY: Diverse secretory of clusterin by epididymis and prostate/seminal vessels undergoing cell repression following orchiectomy. Endocrinology 1990, 126:2989-2997
38. Ahuja HS, Tenniswood M, Lockshin R, Zakeri ZF: Expression of clusterin in cell differentiation and cell death. Biochem Cell Biol 1994, 72:523-529
39. Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR, Zirkin BR: Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology 1995, 136:4368-4376
40. Rennie PS, Bruchovsky N, Coldman AJ: Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes. J Steroid Biochem Mol Biol 1990, 37:843-847
41. Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM, Lee C: Prevention of cell death induced by tumor necrosis factor a in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 1995, 55:2431-2437
42. Dixon SC, Soriano BJ, Lush RM, Borner MM, Figg WD: Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Ann Pharmacol 1997, 31:76-82
43. Bergman PJ, Harris D: Radioresistance, chemoresistance, and apoptosis resistance: the past, present, and future. Vet Clin North Am Small Anim Pract 1997, 27:47-57
44. McConkey DJ, Zhivotovsky B, Orrenius S: Apoptosis: molecular mechanisms and biomedical implications. Mol Aspects Med 1996, 17:1-110
45. Schott AF, Apel IJ, Nunez G, Clarke MF: Bel-XL protects cancer cells from p53-mediated apoptosis. Oncogene 1995, 11:1389-1394
46. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S, Hanada M: BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 1996, 60:23-32
47. Tu H, Jacobs SC, Borkowski A, Kyprianou N: Incidence of apoptosis and cell proliferation in prostate cancer, relationship with TGF-β1 and bcl-2 expression. Int J Cancer 1996, 69:357-363
48. Leav I, Galluzzi CM, Ziar J, Stork PJ, Ho SM, Loda M: Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. Lab Invest 1996, 75:361-370
49. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M: Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest 1997, 76:37-51